Cancer Grading Manual

(2)
Cancer Grading Manual image
ISBN-10:

3662517701

ISBN-13:

9783662517703

Edition: Softcover reprint of the original 2nd ed. 2013
Released: Aug 23, 2016
Publisher: Springer
Format: Paperback, 232 pages
Related ISBN: 9783642345159

Description:

This is the second edition of a practice-oriented, well-illustrated manual on the microscopic grading of tumors. After an introduction on the history and basic tenets of tumor grading, subsequent chapters focus on specific organ systems. In each case, the most widely used system for grading common tumors is presented and discussed. Throughout, careful attention is paid to the principles of microscopic tumor grading, ancillary methods to improve grading, and the latest techniques used in evaluating tumors and formulating prognosis. Since the first edition, all chapters have been updated to reflect revisions in the clinical practice of pathology and to explain the role of novel immunohistochemistry and molecular biology techniques. In addition, a new chapter is devoted to the latest trends in cancer grading, and further illustrations have been included. Cancer Grading Manual is a superb resource for both diagnostic surgical pathologists and pathology residents.

Best prices to buy, sell, or rent ISBN 9783662517703




Frequently Asked Questions about Cancer Grading Manual

You can buy the Cancer Grading Manual book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $112.47 on Amazon and is available from 10 sellers at the moment.

If you’re interested in selling back the Cancer Grading Manual book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Cancer Grading Manual book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.